Despite the gaps in the understanding of KLF4 and its interplay with cell motility and proliferation pathways, we present a novel function for the KLF4-miR-1 axis—a new putative predictive and surveillance biomarker of antiandrogen therapy for advanced prostate cancer. Here, KLF4 is linked to prostate carcinoma.